Standardisation of information submitted to an endpoint committee for cause of death assignment in a cancer screening trial – lessons learnt from CAP (Cluster randomised triAl of PSA testing for Prostate cancer)-Reference-Cited by-同舟云学术

Standardisation of information submitted to an endpoint committee for cause of death assignment in a cancer screening trial – lessons learnt from CAP (Cluster randomised triAl of PSA testing for Prostate cancer)

Published:2015-01-23 Issue:1 Volume:15 Page:
ISSN:1471-2288
Container-title:BMC Medical Research Methodology
language:en
Short-container-title:BMC Med Res Methodol

Author:

Williams Naomi J, ,Hill Elizabeth M,Ng Siaw Yein,Martin Richard M,Metcalfe Chris,Donovan Jenny L,Evans Simon,Hughes Laura J,Davies Charlotte F,Hamdy Freddie C,Neal David E,Turner Emma L

Publisher

Springer Science and Business Media LLC

Subject

Health Informatics,Epidemiology

Link

http://link.springer.com/article/10.1186/1471-2288-15-6/fulltext.html

Reference25 articles.

1. Miller AB, Yurgalevitch S, Weissfeld JL: Death review process in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial.Control Clin Trials 2000,21(6):400S-406S. 10.1016/S0197-2456(00)00095-7

2. De Koning HJ, Blom J, Merkelbach JW, Raaijmakers R, Verhaegen H, Van Vliet P, et al.: Determining the cause of death in randomized screening trial(s) for prostate cancer.BJU Int 2003, 92:71–78. 10.1111/j.1465-5101.2003.04402.x

3. Otto S, van Leeuwen P, Hoekstra J, Merckelbach J, Blom J, Schröder F, et al.: Blinded and uniform causes of death verification in cancer screening: A major influence on the outcome of a prostate cancer screening trial?Eur J Cancer 2010,46(17):3061–3067. 10.1016/j.ejca.2010.09.026

4. Horeweg N, Van Klaveren R, Groen H, Lammers JW, Weenink C, Nackaerts K, et al.: Blinded and uniform cause of death verification in a lung cancer CT screening trial.Lung Cancer 2012,77(3):522–525. 10.1016/j.lungcan.2012.04.018

5. Karch SB, Rutherford JD: Death certification in the UK.JRSM 2003,96(9):425–427. 10.1258/jrsm.96.9.425

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality;JAMA;2024-05-07

2. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer;New England Journal of Medicine;2023-04-27

3. Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials—an ovarian cancer exemplar;Trials;2021-01-25

4. Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT;Health Technology Assessment;2020-08

5. Uniform and blinded cause of death verification of the NELSON lung cancer screening participants;Lung Cancer;2017-09